Joseph Bakare
The National Primary Health Care Development Agency, NPHCDA, said it has not received any official report of serious adverse effects from the 215, 277, so far vaccinated with the COVID-19 Oxford AstraZeneca.
The NPHCDA Executive Director, Dr Faisal Shuaib, disclosed this via the agency’s official Twitter handle, on Wednesday, March 24.
“As you are aware, AstraZeneca/Oxford COVID-19 vaccines have been distributed to all states; except Kogi and the first phase of our vaccination focusing on frontline health workers and others on essential duties have begun in earnest,” he said.
He said that the 215, 277 vaccinated people were from 32 states and the Federal Capital Territory, whereas no vaccination have been recorded in Kebbi, Zamfara, and Oyo State.
“Kogi is yet to receive vaccines because its cold chains for preservation of the vaccines are under repair,” he said.
The agency said that the proportion of Nigerians vaccinated is 5.5 per cent and that Nigeria proposes to vaccinate 70 per cent of eligible population by 2022; adding that this is to reach herd immunity and exit the pandemic.
The agency stated that five states have the highest number of vaccination; with Lagos getting 58,461, followed by Bauchi with 23,827, Jigawa – 20,800 , Ogun – 19,257 and Kaduna -14,527 while the state with the lowest vaccination figure were Ebonyi with 77; followed by Sokoto- 98 and Akwa Ibom with 127.
The FCT where the vaccination was launched, has 8, 616 people vaccinated.